Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dermtech Inc (NQ: DMTK )

1.480 -0.050 (-3.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dermtech Inc

< Previous 1 2 3 4 Next >
30 Stocks Moving in Wednesday's Pre-Market Session
Gainers RenovoRx, Inc. (NASDAQ: RNXT) rose 113% to $11.50 in pre-market trading. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a... 
Via Benzinga
DermTech's Return On Capital Employed Overview
DermTech (NASDAQ:DMTK) brought in sales totaling $3.12 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 29.03%, resulting in a loss of $17... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the... 
Via Benzinga
3 Things About DermTech That Smart Investors Know
These three facts can help you determine whether you want in on this fast-growing company. 
Via The Motley Fool
Recap: DermTech Q2 Earnings
Shares of DermTech (NASDAQ:DMTK) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 1.72% over the past year to ($0... 
Via Benzinga
Recap: DermTech Q1 Earnings
Shares of DermTech (NASDAQ:DMTK) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 3.77% over the past year to ($0... 
Via Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces... 
Via Benzinga
How DermTech Could Change Skin Cancer Testing -- Or Fizzle Out
DermTech's innovative skin treatment is making it easier and cheaper to test for skin cancer, causing the business to grow. Fast. 
Via The Motley Fool
Should Investors Be Concerned About DermTech?
Be concerned? No. Be patient? Yes. 
Via The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
Their growth prospects are massive. 
Via The Motley Fool
Looking into DermTech's Return on Capital Employed
Pulled from Benzinga Pro data DermTech (NASDAQ:DMTK) reported Q2 sales of $3.12 million. Earnings fell to a loss of $17.31 million, resulting in a 29.03% decrease from last... 
Via Benzinga
Why Shares of DermTech Dropped 19% in July
The company's noninvasive skin genomics platform has great potential, but its losses have made investors wary. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) s... 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
This Medical Device Company Is Changing the Game in Skin Cancer
And it's on sale right now. 
Via The Motley Fool
Cramer Weighs In On FireEye, 3D Systems, More
On CNBC's "Mad Money Lightning Round," Jim Cramer revealed he prefers Crowdstrike Holdings Inc (NASDAQ: CRWD), Zscaler Inc (NASDAQ: ZS) and Palo Alto Networks Inc (... 
Via Benzinga
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19
8 Stocks With The Highest Short Percent Of Float Right Now
Traders often look at short interest to get a sense of how many people are bearish on a stock and how strong the possibility of a short squeeze is. But simply looking at the size... 
Via Benzinga
Step Aside AMC: Here Are The Most Shorted Stocks Right Now
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more... 
Via Talk Markets
What Investors Should Look for With Exelixis, DermTech, and Teladoc Health
All three healthcare stocks could have solid growth prospects. 
Via The Motley Fool
High Flyers At Much Lower Altitudes
Stocks with extreme valuations have taken a serious haircut since the space peaked on February 22nd. 
Via Talk Markets
74 Biggest Movers From Friday
Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares... 
Via Benzinga
28 Stocks Moving in Friday's Pre-Market Session
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 28.5% to $0.7451 in pre-market trading after the company reported better-than-expected Q1 sales. Bionano Genomics, Inc. (NASDAQ:... 
Via Benzinga
54 Stocks Moving In Friday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) shares jumped 44.5% to $12.93 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares jumped 39.8% to $4.04. MoSys, last week... 
Via Benzinga
13 Stocks Moving In Thursday's After-Hours Session
Gainers DoorDash (NYSE: DASH) shares are trading higher after the company reported better-than-expected Q1 sales results. Bionano Genomics (NASDAQ: BNGO) shares are trading higher... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Exposures COVID-19 Product Safety
3 Stocks I Fully Expect to Double or More Within the Next 5 Years
The prospects of great returns look really good for these stocks. 
Via The Motley Fool
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.